Analystreport

Correvio Pharma Corp (NASDAQ: CORV) was upgraded by analysts at Mackie from a "hold" rating to a "buy" rating.

CORREVIO PHARMA CORP ORDINARY SHARES  (CORV) 
Last correvio pharma corp ordinary shares earnings: 11/14 07:00 am Check Earnings Report